Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes

Clinical trial NCT00953420 · COMPLETED

Trial details

NCT number: NCT00953420
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2009-11-01
Primary completion: 2014-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.